MCMark CottonMD, PhDVideoHIVRSVInternational Workshop on Pediatrics & HIV 2024Update on Analytic Treatment Interruption Consensus Guidelines for HIV Cure/Control - Mark CottonView Video
DPDeborah PersaudMDVideoHIVRSVInternational Workshop on Pediatrics & HIV 2024Update on Cure Agenda - Deborah PersaudView Video
MCMark CottonMD, PhDVideoHIVRSVInternational Workshop on Pediatrics & HIV 2024From CHER to Cure: How a Pivotal Trial Helped to Shape the HIV Cure/Control Agenda in Children & Adolescents - Mark CottonView Video
VideoHIVRSVInternational Workshop on Pediatrics & HIV 2024#24 - In-Utero Exposure to High Tenofovir Concentration Is Associated With Lower Bone Mineral Content in HIV-Unexposed Infants - Kimesh - NaidooView Video
VideoHIVRSVInternational Workshop on Pediatrics & HIV 2024#23 - Genotypic Resistance to Integrase Inhibitors, Protease Inhibitors and Tenofovir Alafenamide Is Uncommon in Children With Virological Rebound in the CHAPAS-4 Randomised Trial of Second-Line Antiretroviral Therapy for Children With HIV - Cissy KityoView Video
VideoHIVRSVInternational Workshop on Pediatrics & HIV 2024#22 - Trends in Infant HIV Positivity and Linkage to ART among HIV-Exposed Infants Aged <12 Months in PEPFAR-Supported Programs, FY2018-FY2023 - Elizabeth M. RaboldView Video
VideoHIVRSVInternational Workshop on Pediatrics & HIV 2024#21- Hospital Outcomes From a Cohort of Mozambican HIV-Exposed Uninfected and HIV-Unexposed Infants - Chris BuckView Video
PMPhilippa MusokeMBChB, FAAP, PhDVideoHIVRSVInternational Workshop on Pediatrics & HIV 2024Debate: No Infant Antiretroviral Prophylaxis for Infants Born to Mothers with HIV Who Are Virally Suppressed - Philippa MusokeView Video
JBJason BrophyMD, MSc, DTM, FRCPCVideoHIVRSVInternational Workshop on Pediatrics & HIV 2024Debate: No Infant Antiretroviral Prophylaxis for Infants Born to Mothers with HIV Who Are Virally Suppressed - Jason BrophyView Video
VideoHIVRSVInternational Workshop on Pediatrics & HIV 2024#15 - Pharmacokinetics and Safety of Dolutegravir in Neonates Exposed to HIV-1 (IMPAACT 2023) - Hardik ChandasanaView Video
VideoHIVRSVInternational Workshop on Pediatrics & HIV 2024#14 - Safety Outcomes Among Infants Whose Mothers Used Dapivirine Vaginal Ring or Oral PrEP During Pregnancy (MTN- 042/DELIVER) - Lee FairlieView Video
ACAleny CoutoMDVideoHIVRSVInternational Workshop on Pediatrics & HIV 2024#13 - High Vertical Transmission Rate Among HIV-Exposed Infants up to 9 Months of Age Born to Newly Identified Breastfeeding Women Tested at the Well-Child Clinic: Results From a Pilot in Mozambique - Aleny CoutoView Video
